Your Location：
Home >
Browse articles >
Mechanism of Astragaloside Ⅳ in Treating Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking
Mechanism of Astragaloside Ⅳ in Treating Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 13, Pages: 209-216(2022)
DOI： 10.13422/j.cnki.syfjx.20220716
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 5 )
References
Publication Info
Metrics
259
Views
365
Downloads
8
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Analysis on Mechanism of Astragali Radix in Treating IgA Nephropathy Based on Network Pharmacology and in Vitro Cell Experiment
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
Molecular Mechanism of Tangbikang Granules Against Diabetic Peripheral Neuropathy： Based on Network Pharmacology and Experimental Verification
Molecular Mechanism of Erxian Decoction in Treatment of Anxiety Disorder Based on Network Pharmacology and Experimental Verification
Related Author
Shuang PANG
Shuan ZHAO
Xia-lian XU
Jia-wei YU
Xiao-qiang DING
CHANG Liya
LENG Yufang
ZHAO Zicen
Related Institution
Fudan University
Shanghai Key Laboratory of Kidney Disease and Blood Purification，Shanghai Clinical Medical Center of Kidney Disease，Zhongshan Hospital Affiliated to Fudan University
The First Clinical Medical College of Lanzhou University
The First Hospital of Lanzhou University
Hunan University of Traditional Chinese Medicine
Chat
